The success of Vertex's opioid alternative Journavx could aid a group of biotechs that aim to take a similar path with NaV1.8 ...

Sodium channel blocker shows promise as a potential treatment for cystic fibrosis Peer-Reviewed Publication. American ... "Cystic fibrosis patients have a genetic ion transport defect, ...

ATS 2009: Novel Aerosol Epithelial Sodium-Channel Blocker Shows Promise for Cystic Fibrosis. ... and is connected to the ion-transport defects, which are well recognized in CF.

Cystic Fibrosis: Sodium Channel Blocker Shows Promise As Potential Treatment For CF. ScienceDaily . Retrieved June 4, 2025 from www.sciencedaily.com / releases / 2009 / 05 / 090517143226.htm ...

ASN008 is a permanently positively charged sodium channel blocker. ... a highly selective antagonist of the purinergic P2X3 ion channel that is activated by extracellular ATP and involved in ...

Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Antiarrhythmic Drugs Market Size, Share & Trends Analysis Report By Drug Class (Beta Blockers, Sodium Channel Blockers), By Route of Administration ...

Sodium channel blockers for pain: New opportunities after Vertex’s ‘watershed’ moment Certain ion channels in peripheral nerve cells transmit pain signals, making them a target for drug ...